Regeneron Pharmaceuticals Inc (REGN)

Debt-to-assets ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Long-term debt	US$ in thousands	1,984,400	1,984,000	1,983,600	1,983,300	1,982,900	1,982,600	1,982,200	1,981,800	1,981,400	1,981,100	1,980,700	1,980,400	1,980,000	1,979,600	1,979,200	1,978,900	1,978,500	1,978,300	—	—
Total assets	US$ in thousands	37,759,400	37,441,900	36,086,800	34,369,600	33,080,200	32,163,300	30,657,500	30,059,900	29,214,500	27,677,800	27,205,800	26,348,700	25,434,800	23,671,500	21,485,900	17,772,200	17,163,300	16,084,000	14,428,700	15,757,500
Debt-to-assets ratio		0.05	0.05	0.05	0.06	0.06	0.06	0.06	0.07	0.07	0.07	0.07	0.08	0.08	0.08	0.09	0.11	0.12	0.12	0.00	0.00

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $1,984,400K ÷ $37,759,400K
= 0.05

The debt-to-assets ratio of Regeneron Pharmaceuticals Inc has been consistently low over the analyzed period, indicating a strong financial position with a low level of debt in relation to its total assets. The ratio remained at 0.00 for the first two quarters of 2020, signifying that the company had no debt in relation to its assets during that time.

From September 2020 onwards, the debt-to-assets ratio started to increase gradually, reaching 0.12 by the end of December 2020. However, the ratio began to decrease slightly in the following periods, reaching 0.06 by June 2024. This indicates that the company has been effectively managing its debt levels in relation to its assets.

Overall, the decreasing trend in the debt-to-assets ratio suggests that Regeneron Pharmaceuticals Inc has been using its assets efficiently and has been able to generate sufficient returns to cover its debt obligations. A low debt-to-assets ratio generally indicates lower financial risk and greater financial stability for the company.